Co-funding Institute(s):
National Cancer Institute (NCI)
Osteonecrosis in Pediatric and Adolescent ALL: Insights into the Etiology of this Emerging Toxicity
Fall 2009
Bethesda/Rockville, MD, United States
Description<p> </p><span style="FONT-SIZE: 12pt; FONT-FAMILY: 'Times New Roman'">The effectiveness of the workshop will be assessed by tracking the number of collaborations established between investigators and incorporation of these investigations into clinical protocols. The number of objectives relating to osteonecrosis in future ALL protocols will be tracked which could potentially impact quality of life issues and cancer survivorship. The incidence of osteonecrosis will also be tracked and compared in current and future ALL studies. Electronic post meeting evaluation</span>
Contact for additional information: Dr. Nita L. Seibel, 301-435-9204
Additional Information:
|